Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J Am Coll Cardiol. 2002 Dec 04; 40(11):2006-12.
View in:
PubMed
subject areas
3',5'-Cyclic-GMP Phosphodiesterases
3',5'-Cyclic-GMP Phosphodiesterases
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Blood Pressure
Blood Pressure
Cardiovascular System
Cardiovascular System
Coronary Artery Disease
Coronary Artery Disease
Cross-Over Studies
Cross-Over Studies
Cyclic Nucleotide Phosphodiesterases, Type 5
Cyclic Nucleotide Phosphodiesterases, Type 5
Diastole
Diastole
Double-Blind Method
Double-Blind Method
Electrocardiography
Electrocardiography
Erectile Dysfunction
Erectile Dysfunction
Exercise
Exercise
Exercise Test
Exercise Test
Exercise Tolerance
Exercise Tolerance
Heart Rate
Heart Rate
Humans
Humans
Imidazoles
Imidazoles
Male
Male
Middle Aged
Middle Aged
Phosphodiesterase Inhibitors
Phosphodiesterase Inhibitors
Phosphoric Diester Hydrolases
Phosphoric Diester Hydrolases
Piperazines
Piperazines
Sulfones
Sulfones
Systole
Systole
Treatment Outcome
Treatment Outcome
Triazines
Triazines
Vardenafil Dihydrochloride
Vardenafil Dihydrochloride
authors with profiles
Udho Thadani